Drug Approval | June 14, 2024
EDQM has also issued a Certificate of Suitability for Allopurino
Accelerating sustainability in Indian pharma industry
The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress
New data on the secondary endpoint shows up to 52.3% of adults with fibrosis stages F1, F2 and F3 had improvement in fibrosis due to MASH
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
Ashkenazi will continue to serve at full capacity in her role and as a member of Lilly's Executive Committee through July 2024
This strategic decision will unlock significant value for our scientific and industrial products business
Dr. Reddy's Laboratories gets Form 483 from USFDA with 4 observations for API facility
The transaction aligns with Lupin's strategy to grow its global presence in Specialty areas
Subscribe To Our Newsletter & Stay Updated
